Il-13 antibodies for the treatment of atopic dermatitis
TW202639170APending Publication Date: 2026-10-01DERMIRA INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW115106722
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-03-08
- Filing Date
- 2024-03-08
- Publication Date
- 2026-10-01
Smart Images
Figure 00000000_0000_ABST
Abstract
Provided herein are methods, uses and pharmaceutical compositions of antibodies that bind human IL-13 ("anti-IL-13 antibodies") for treating atopic dermatitis, e.g., in a patient who has been previously administered dupilumab.
Need to check novelty before this filing date? Find Prior Art